Antibiotic Treatment ofMycobacterium abscessusLung Disease

A Novel Gene, erm(41), Confers Inducible Macrolide Resistance to Clinical Isolates of Mycobacterium abscessus but Is Absent from Mycobacterium chelonae

(2009) K. A. Nash et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Screening for Sterilizing Activity of Antibiotic Combinations in an Acid Model of Rapidly Growing Mycobacteria during the Stationary Phase of Growth

(2009) R. Cremades et al.   CHEMOTHERAPY

Epidemic of Postsurgical Infections Caused by Mycobacterium massiliense

(2009) R. S. Duarte et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Mycobacterium abscessus from respiratory isolates: activities of drug combinations

(2009) Rosa Cremades et al.   JOURNAL OF INFECTION AND CHEMOTHERAPY

Daily half-dose linezolid for the treatment of intractable multidrug-resistant tuberculosis

(2008) Hae-Seong Nam et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Spread of nontuberculous mycobacteria from 1993 to 2006 in Koreans

(2008) Sung Weon Ryoo et al.   JOURNAL OF CLINICAL LABORATORY ANALYSIS

Proportions of Mycobacterium massiliense and Mycobacterium bolletii Strains among Korean Mycobacterium chelonae-Mycobacterium abscessus Group Isolates

(2008) H.-Y. Kim et al.   JOURNAL OF CLINICAL MICROBIOLOGY

In Vitro Antimicrobial Susceptibility of Mycobacterium abscessus in Korea

(2008) Sunghoon Park et al.   JOURNAL OF KOREAN MEDICAL SCIENCE

When and how to treat pulmonary non-tuberculous mycobacterial diseases

(2008) Rachel M. THOMSON et al.   RESPIROLOGY

Diagnosis and Treatment of Infections Caused by Rapidly Growing Mycobacteria

(2008) Rhonda Colombo et al.   SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE